MORPHABOND ER with SentryBond Technology

MORPHABOND ER with SentryBond Technology

divider-arrow

A single-agent, abuse-deterrent morphine with bioequivalence to MS Contin®1,2

Retains its extended-release properties even if manipulated1,2

Expected to deter intranasal and intravenous abuse1,2

Abuse of MORPHABOND ER is still possible by intranasal, intravenous, and oral routes


commitments

commit-page

Daiichi Sankyo is committed to responsible use of prescription pain medications